Affiliation:
1. Department of Microbiology, Medical College of Wisconsin, Milwaukee 53226.
Abstract
Alpha interferon (IFN-alpha) and acyclovir (ACV) are synergistic in their anti-herpes simplex virus activities. IFN-alpha treatment reduced the herpes simplex virus thymidine kinase (TK) activity present in cells 6 h postinfection, while steady-state levels of TK mRNA remained at or above the amount in infected, untreated cells. The inhibition of TK production by IFN-alpha treatment appeared to be transient and translational, not transcriptional.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference28 articles.
1. Interferon inhibits herpes simplex virus-specific translation: a reinvestigation;Altinkilic B.;J. Gen. Virol.,1988
2. Ausubel F. M. R. Brent R E. Kingston D. D. Moore J. G. Seidman J. A. Smith and K. Struhl. 1987. Current protocols in molecular biology p. 4.9.7. Greene Publishing Associates and Wiley-Interscience New York.
3. Trans-activation of herpes simplex virus type 1 immediate early genes is specifically inhibited by human recombinant interferons;DeStasio R. R;Biochem. Biophys. Res. Commun.,1989
4. Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase;Furman P. A.;J. Biol. Chem.,1984
5. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl) guanine;Fyfe J. A.;Proc. Natl. Acad. Sci. USA,1978
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献